Home » Taurolock Urokinase™
Catheter lock solution with double effectiveness
TauroLock™ is a preventive lock solution suitable for central venous access within haemodialysis and oncology. In order to ensure a catheter with an optimum blood flow, it is important that the lock solution ensures both clotting and infection prevention. Taurolock’s double effectiveness prevents catheter infections and clot formation.
The double effectiveness of TauroLock Urokinase consists of the combination of:
Besides solving flow problems through the urokinase, TauroLock Urokinase also prevents new formation of clots.
4% citrate (anti-clotting effect), 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE) and 5000 IU/mL urokinase (intensive anticoagulant)
5 ml glass ampoule, vial with lyophilised urokinase injection powder
Combination of 5 ampoules and 5 vials each per box